| Description | gene mutations in cancer cell lines from low-throughput or high-throughput studies |
| Measurement | gene mutation by data aggregation |
| Association | gene-cell line associations by mutation of gene in cell line |
| Category | genomics |
| Resource | Catalogue of Somatic Mutations In Cancer |
| Citation(s) |
|
| Last Updated | 2015 Apr 06 |
| Stats |
|
| API | |
| Script | |
| Downloads |
Attribute Similarity
Gene Attribute
Gene Similarity
1026 sets of genes mutated in cell lines from the COSMIC Cell Line Gene Mutation Profiles dataset.
| Gene Set | Description |
|---|---|
| 201T | cell line derived from -666 |
| 22RV1 | Human prostate carcinoma cell line; derived from a human prostate carcinoma xenograft (CWR22R) that was serially propagated in nude mice after castration-induced regression and relapse of the parental, androgen-dependent CWR22 xenograft. |
| 23132-87 | |
| 42-MG-BA | |
| 451LU | |
| 5637 | |
| 639-V | disease: carcinoma, transitional cell |
| 647-V | |
| 697 | Human B cell precursor leukemia; established from the bone marrow of a 12-year-old boy with acute lymphoblastic leukemia (cALL) at relapse in 1979. |
| 769-P | |
| 786-0 | This line was derived from a primary clear cell adenocarcinoma. The karyotype is hypertriploid; Y was present in 60% the cells examined. The cells display both microvilli and desmosomes, and can be grown in soft agar. The cells produce a PTH like peptides that is identical to peptides produced by breast and lung tumors. |
| 8-MG-BA | |
| 8305C | Human thyroid carcinoma cell line, established from the primary tumor of a 67-year-old woman with primary thyroid undifferentiated carcinoma. |
| 8505C | Established from undifferentiated thyroid carcinomas of a 78 year old female patient. |
| A101D | |
| A172 | A immortal human brain-derived cell line cell that has the characteristics: Human cell line derived from glioblastoma. TKG0183(Deposited from Tohoku Univ.). |
| A204 | |
| A2058 | Human skin melanoma cell line, established from a 43 years adult caucasian male. |
| A253 | |
| A2780 | Human ovarian carcinoma cell line. |
| A3-KAW | |
| A375 | |
| A388 | |
| A4-FUK | |
| A427 | |
| A431 | Human epidermoid carcinoma established from the solid tumor of an 85-year-old woman; cells were reported to have large numbers of EGF binding sites; cell line was used as indicator cell line for anti-TGF binding. |
| A498 | |
| A549 | Human lung carcinoma established from an explanted lung tumor which was removed from a 58-year-old Caucasian man in 1972; cells were described to induce tumors in athymic mice and to synthesize lecithin. |
| A673 | |
| A704 | Human kidney adenocarcinoma cell line, established from a 78 years old male. |
| ABC-1 | |
| ACHN | |
| ACN | |
| AGS | |
| ALL-PO | |
| ALL-SIL | Human T cell leukemia established from the peripheral blood of a 17-year-old man with T cell acute lymphoblastic leukemia, T-ALL. |
| AM-38 | |
| AMO-1 | cell line derived from haematopoietic_and_lymphoid_tissue |
| AN3-CA | |
| ARH-77 | Human plasma cell leukemia cell line, established from the peripheral blood of a 33-year-old woman with IgG plasma cell leukemia; cell line is widely used as model for multiple myeloma/plasma cell leukemia, but cells are clearly EBV+ indicating that ARH-77 might be rather a normal B-lymphoblastoid cell line than a tumor cell line. |
| ASH-3 | cell line derived from -666 |
| ASPC-1 | |
| ATN-1 | A immortal human blood cell line cell that has the characteristics: Adult T-cell leukemia. HTLV-1 pro-virus DNA(+). |
| AU565 | |
| BALL-1 | Human acute lymphoblastoid leukemia cell line from peripheral blood. |
| BB30-HNC | |
| BB49-HNC | |
| BB65-RCC | |
| BC-1 | |
| BC-3 | |
| BCPAP | Human papillary thyroid carcinoma derived cell line. |
| BE-13 | |
| BE2-M17 | Human caucasian neuroblastoma cell line. The cell line BE(2)-M17 was isolated from SK-N-BE(2) by limiting dilution. |
| BECKER | |
| BEN | Human lung carcinoma; established from the supraclavicular tumor cells-containing lymph node of a 71-year-old man with poorly differentiated carcinoma of the lung. |
| BFTC-905 | |
| BFTC-909 | disease: carcinoma, transitional cell |
| BHT-101 | |
| BHY | Oral squamous cell carcinoma cell line. |
| BICR10 | cell line derived from oral cavity |
| BICR22 | cell line derived from upper aerodigestive tract |
| BICR31 | cell line derived from upper_aerodigestive_tract |
| BICR78 | cell line derived from oral cavity |
| BL-41 | Human Burkitt lymphoma cell line; established from the tumor tissue of an 8-year-old Caucasian boy with Burkitt lymphoma. |
| BL-70 | Human Burkitt lymphoma cell line; established from the tumor tissue at relapse of a 16-year-old Caucasian boy with Burkitt lymphoma. |
| BONNA-12 | disease: leukemia, hairy cell |
| BPH-1 | Human benign prostate hyperplasia; prostate epithelial cells from a 68-year-old man with benign prostate hyperplasia; cells were immortalized with SV-40 large T-antigen; cells were described to express cytokeratins 8, 18, and 19 (but not 14) and to metabolize prostatic androgens. |
| BT-20 | Human, Caucasian, breast, carcinoma cell line. Morphology: epithelial-like; species: human, Caucasian female 74 years old; tissue: breast; tumor: carcinoma. |
| BT-474 | |
| BT-483 | |
| BT-549 | |
| BV-173 | |
| BXPC-3 | Human pancreatic adenocarcinoma cell line, established from a 61 year old human female. |
| C-33-A | |
| C-4-I | |
| C2BBE1 | The C2BBe1 (brush border expressing) cell line was cloned in 1988 from the Caco-2 cell line by limiting dilution. |
| C32 | |
| C3A | |
| CA-SKI | A immortal human uterine cervix-derived cell line cell that has the characteristics: Human cell line derived from uterine cervical epidermoid carcinoma. TKG0366(Deposited from Tohoku Univ.). |
| CA46 | |
| CA9-22 | A immortal human gingiva-derived cell line cell that has the characteristics: Human gingival carcinoma cell line. Expressing remarkable EGF receptor. HLA-A 2/24. TKG0485(Deposited from Tohoku Univ.). |
| CADO-ES1 | |
| CAKI-1 | |
| CAL-120 | disease: adenocarcinoma, breast |
| CAL-12T | |
| CAL-148 | disease: adenocarcinoma, breast |
| CAL-27 | Human tongue squamous cell carcinoma established from the poorly differentiated squamous cell carcinoma of the tongue removed from a 56-year-old man before treatment in 1982. |
| CAL-29 | cell line derived from urinary_tract |
| CAL-33 | Human tongue squamous cell carcinoma established from the surgically removed fragment of a tongue lesion from a 69-year-old man with moderately differentiated squamous cell carcinoma of the tongue in 1983 (prior to therapy). |
| CAL-39 | disease: carcinoma, squamous cell |
| CAL-51 | |
| CAL-54 | |
| CAL-62 | |
| CAL-72 | Human osteosarcoma cell line, established from a chemotherapy-resistant tumor sample obtained from the left knee of a 10-year-old boy with anaplastic osteoblastic sarcoma (Rosen grade IIB) in 1989. |
| CAL-78 | |
| CAL-85-1 | disease: adenocarcinoma, breast |
| CALU-3 | |
| CALU-6 | |
| CAMA-1 | |
| CAOV-3 | |
| CAOV-4 | disease: adenocarcinoma (ovary primary) |
| CAPAN-1 | |
| CAPAN-2 | |
| CAR-1 | Human rectal carcinoma cell line. |
| CAS-1 | |
| CCF-STTG1 | |
| CCK-81 | cell line derived from large_intestine |
| CCRF-CEM | |
| CESS | |
| CFPAC-1 | This line was derived from a pancreatic duct adenocarcinoma (liver metastasis) from a patient with cystic fibrosis. |
| CGTH-W-1 | |
| CHAGO-K-1 | |
| CHL-1 | |
| CHP-126 | Human neuroblastoma cell line. |
| CHP-134 | A immortal human adrenal gland-derived cell line cell that has the characteristics: N-myc gene amplification |
| CHP-212 | |
| CHSA0011 | cell line derived from -666 |
| CHSA0108 | cell line derived from -666 |
| CHSA8926 | cell line derived from -666 |
| CL-11 | Human lung adenocarcinoma cell line. |
| CL-34 | cell line derived from large_intestine |
| CL-40 | cell line derived from large_intestine |
| CMK | |
| CML-T1 | disease: leukemia, T cell |
| COLO-205 | |
| COLO-320-HSR | disease: colorectal adenocarcinoma |
| COLO-668 | disease: carcinoma, oat cell |
| COLO-678 | |
| COLO-679 | |
| COLO-680N | disease: carcinoma, squamous cell |
| COLO-684 | |
| COLO-741 | disease: carcinoma, colon |
| COLO-783 | |
| COLO-792 | disease: malignant melanoma |
| COLO-800 | |
| COLO-824 | |
| COLO-829 | disease: malignant melanoma |
| COR-L105 | |
| COR-L23 | disease: carcinoma, large cell |
| COR-L279 | disease: carcinoma, small cell |
| COR-L303 | cell line derived from -666 |
| COR-L311 | disease: carcinoma, small cell |
| COR-L32 | cell line derived from -666 |
| COR-L321 | cell line derived from -666 |
| COR-L88 | disease: carcinoma, lung small cell |
| COR-L95 | disease: carcinoma, small cell |
| CP50-MEL-B | cell line derived from skin |
| CP66-MEL | |
| CP67-MEL | |
| CPC-N | disease: carcinoma, small cell |
| CRO-AP2 | |
| CRO-AP3 | EBV negative PEL cell line. |
| CS1 | cell line derived from -666 |
| CTB-1 | A immortal human cell line cell that has the characteristics: Fas-antigen expressing. Ligation with anti-Fas mAb does not induce apoptosis. |
| CTV-1 | disease: leukemia, acute myeloid |
| CW-2 | A immortal human colon-derived cell line cell that has the characteristics: Colon carcinoma. CEA-positive, nude mouse-transplantable. |
| D-245MG | cell line derived from central_nervous_system |
| D-247MG | |
| D-263MG | |
| D-283MED | |
| D-336MG | |
| D-392MG | |
| D-423MG | |
| D-502MG | |
| D-542MG | |
| D-566MG | |
| DAN-G | |
| DAOY | The Daoy cell line was established in 1985 by P. F Jacobsen of the Royal Perth Hospital in Western Australia. The line was derived from biopsy material taken from a tumor in the posterior fossa of a 4 year old boy. |
| DAUDI | A immortal human blood cell line cell that has the characteristics: Burkitt's lymphoma. Sensitive to lymphokine-activated killer cells but resistant to natural killer cells. Back up culture of ECA3011. |
| DB | disease: large cell lymphoma |
| DBTRG-05MG | |
| DEL | |
| DETROIT562 | |
| DG-75 | |
| DIFI | cell line derived from -666 |
| DJM-1 | A immortal human zone of skin-derived cell line cell that has the characteristics: Malignant trichilemmal cyst cells. Strongly laminin positive on cell surface. Serum-free culturable. |
| DK-MG | |
| DMS-114 | |
| DMS-273 | disease: carcinoma, small cell |
| DMS-53 | |
| DMS-79 | |
| DND-41 | cell line derived from haematopoietic_and_lymphoid_tissue |
| DOHH-2 | |
| DOK | |
| DOTC2-4510 | |
| DOV13 | Ovarian carcinoma cell line. |
| DSH1 | |
| DU-145 | A immortal human prostate gland-derived cell line cell that has the characteristics: Human cell line derived from brain metastasis of prostate carcinoma. TKG0604(Deposited from Tohoku Univ.). |
| DU-4475 | disease: ductal carcinoma |
| EB-3 | disease: Burkitts lymphoma |
| EB2 | disease: Burkitts lymphoma (B lymphocyte primary) |
| EBC-1 | A immortal human cell line cell that has the characteristics: Human lung squamous cell carcinoma cell line. TKG0481(Deposited from Tohoku Univ.). |
| EC-GI-10 | A immortal human esophagus-derived cell line cell that has the characteristics: Produce hypercalcemia in nude mice. PTH-related protein, IL-1alpha producing. |
| ECC10 | A immortal human stomach-derived cell line cell that has the characteristics: Small cell gastrointestinal carcinoma with c-myc overexpression. Cell growth is slow. |
| ECC12 | A immortal human stomach-derived cell line cell that has the characteristics: Small cell gastrointestinal carcinoma showing creatine kinase-BB and aromatic L-amino-acid decarboxy. Cell growth is slow. |
| EFM-19 | |
| EFM-192A | |
| EFO-21 | disease: cystoadenocarcinoma |
| EFO-27 | Human ovary adenocarcinoma cell line; established from the solid omental metastasis of a mucinous papillary adenocarcinoma of the ovary of a 36-year-old woman in 1979. |
| EGI-1 | |
| EHEB | Human chronic B cell leukemia cell line;established from the peripheral blood of a 69-year-old woman with B-CLL (chronic lymphocytic leukemia) prior treatment by EBV-transformation in 1988; cell line may represent rather a B-lymphoblastoid cell line than a bona fide B-CLL cell line. |
| EJM | cell line derived from haematopoietic_and_lymphoid_tissue |
| EKVX | Non-small cell lung adenocarcinoma cell line. |
| EM-2 | disease: leukemia, chronic myeloid |
| EMC-BAC-1 | cell line derived from -666 |
| EMC-BAC-2 | cell line derived from -666 |
| EN | |
| EOL-1-CELL | Human eosinophilic leukaemia cell line. |
| EPLC-272H | disease: carcinoma, epidermoid |
| ES-2 | |
| ES1 | |
| ES3 | |
| ES4 | cell line derived from bone |
| ES5 | |
| ES6 | |
| ES7 | |
| ES8 | |
| ESO26 | cell line derived from -666 |
| ESO51 | cell line derived from -666 |
| ESS-1 | disease: sarcoma-stromal |
| ETK-1 | |
| EVSA-T | |
| EW-1 | |
| EW-11 | |
| EW-12 | |
| EW-13 | |
| EW-16 | |
| EW-18 | |
| EW-22 | |
| EW-24 | |
| EW-3 | |
| EW-7 | |
| FADU | Cell line derived from squamous cell carcinoma of the hypopharynx. |
| FARAGE | disease: non-Hodgkins lymphoma |
| FLO-1 | Esophageal adenocarcinoma cell line. |
| FTC-133 | Human thyroid carcinoma cell line; obtained from a lymph node metastasis of a follicular thyroid carcinoma from a 42-year-old male. |
| FU-OV-1 | |
| FU97 | |
| G-292_CLONE_A141B1 | |
| G-361 | Homo sapiens (human); skin; malignant melanoma cell line; established from a 31 year old caucasian male. |
| G-401 | A human cell line derived from a pediatric patient initially classified as Wilm's tumor, reclassified as deriving from a rhabdoid tumor of the kidney |
| G-402 | A human cell line derived from some renal leiomyeloblastoma |
| G-MEL | cell line derived from -666 |
| GA-10 | disease: Burkitts lymphoma |
| GAK | |
| GAMG | Human glioblastoma cell line. |
| GB-1 | cell line derived from central nervous system |
| GCIY | A immortal human stomach-derived cell line cell that has the characteristics: Stomach cancer (Borrmann IV). Mutin, CA19-9, CEA, alphafetoprotein positive Cell growth is slow. |
| GCT | A Giant Cell Tumor (GCT) cell line derived from a human fibrous histiocytoma lung metastasis |
| GDM-1 | disease: monoblast; myelomonoblastic leukemia |
| GEO | Human colon cancer cell line. |
| GI-1 | A immortal human brain-derived cell line cell that has the characteristics: Human glioma separated from gliosarcoma. |
| GI-ME-N | |
| GMS-10 | disease: glioblastoma |
| GOTO | Human glioblastoma cell line. |
| GP5D | |
| GR-ST | A immortal human blood cell line cell that has the characteristics: RCB1181 ST cells transformed with human G-CSF receptor cDNA. Responds to G-CSF. |
| GRANTA-519 | disease: lymphoma, B cell |
| GT3TKB | |
| H-EMC-SS | disease: chondrosarcoma |
| H2369 | cell line derived from -666 |
| H2373 | cell line derived from -666 |
| H2461 | cell line derived from -666 |
| H2591 | cell line derived from -666 |
| H2595 | cell line derived from -666 |
| H2722 | cell line derived from -666 |
| H2731 | cell line derived from -666 |
| H2795 | cell line derived from -666 |
| H2803 | cell line derived from -666 |
| H2804 | cell line derived from -666 |
| H2810 | cell line derived from -666 |
| H2818 | cell line derived from -666 |
| H2869 | cell line derived from -666 |
| H290 | cell line derived from -666 |
| H3118 | cell line derived from -666 |
| H3255 | |
| H4 | |
| H513 | cell line derived from -666 |
| H9 | |
| HA7-RCC | cell line derived from kidney |
| HAL-01 | A immortal human blood cell line cell that has the characteristics: Acute lymphatic leukemia |
| HARA | cell line derived from lung |
| HC-1 | disease: leukemia, hairy cell |
| HCC-15 | |
| HCC-33 | cell line derived from lung |
| HCC-366 | |
| HCC-44 | |
| HCC-56 | cell line derived from large_intestine |
| HCC-78 | |
| HCC-827 | |
| HCC1143 | disease: primary ductal carcinoma |
| HCC1187 | disease: primary ductal carcinoma |
| HCC1395 | |
| HCC1419 | disease: primary ductal carcinoma |
| HCC1428 | disease: adenocarcinoma (mammary gland primary) |
| HCC1500 | disease: primary ductal carcinoma |
| HCC1569 | disease: primary metaplastic carcinoma |
| HCC1599 | disease: primary ductal carcinoma |
| HCC1806 | disease: primary acantholytic squamous cell carcinoma |
| HCC1937 | |
| HCC1954 | |
| HCC202 | disease: primary ductal carcinoma |
| HCC2157 | disease: primary ductal carcinoma |
| HCC2218 | disease: primary ductal carcinoma |
| HCC2998 | |
| HCC38 | |
| HCC70 | disease: primary ductal carcinoma |
| HCE-4 | Human esophageal carcinoma cell line. |
| HCT-116 | Human colon colorectal carcinoma cell line from a male organism. Human colon carcinoma cell line; established from the primary colon carcinoma of an adult man. |
| HCT-15 | |
| HD-MY-Z | |
| HDLM-2 | |
| HDQ-P1 | cell line derived from breast |
| HEC-1 | |
| HEL | Human erythroleukemia, established from the peripheral blood of a 30-year-old man with erythroleukemia (AML M6) in relapse (after treatment for Hodgkin's disease) in 1980; cells were described to be capable of spontaneous and induced globin synthesis. |
| HELA | Human cervix carcinoma established from the epitheloid cervix carcinoma of a 31-year-old black woman in 1951. Later diagnosis changed to adenocarcinoma, first aneuploid, continuously cultured human cell line. |
| HEP_3B2_1-7 | disease: hepatocellular carcinoma |
| HEY | Human ovarian carcinoma cell line. |
| HGC-27 | This human gastric carcinoma cell line was established by culture of the metastatic lymph node from a gastric cancer patient diagnosed histological as undifferentiated carcinoma. |
| HH | |
| HL-60 | Human acute myeloid leukemia established from the peripheral blood of a 35-year-old woman with acute myeloid leukemia (AML FAB M2) in 1976. |
| HLE | Human lens epithelial cell line. |
| HMV-II | A immortal human cell line cell that has the characteristics: Melanin producing. Originated from the same site of HMV-I. |
| HN | Oral squamous cell carcinoma cell line. |
| HO-1-N-1 | |
| HO-1-U-1 | A immortal human mouth-derived cell line cell that has the characteristics: Human cell line derived from squamous cell carcinoma at mouth floor. TKG0455(Deposited from Tohoku Univ.). |
| HOP-62 | Non-small cell lung adenocarcinoma cell line. |
| HOP-92 | Non-small cell lung adenocarcinoma cell line. |
| HOS | |
| HPAC | |
| HPAF-II | |
| HS-445 | disease: lymphoma; Hodgkins disease |
| HS-578-T | |
| HS633T | |
| HS683 | Human brain glioma cell line. Hs 683 was isolated from explant cultures of a glioma taken from the left temporal lobe of a 76 year old male Caucasian. |
| HS746T | disease: gastric carcinoma (stomach primary |
| HS766T | Human pancreatic cancer cell line. |
| HS939-T | |
| HS940-T | disease: malignant melanoma |
| HSC-2 | A immortal human mouth-derived cell line cell that has the characteristics: Human cell line derived from oral squamous cell carcinoma occurred in 69-yo, male patient. HLA-A 24/. TKG0487 (Deposited from Tohoku Univ.). |
| HSC-3 | A immortal human tongue-derived cell line cell that has the characteristics: Human tongue squamous cell carcinoma cell line. HLA-A 2/24. TKG0484(Deposited from Tohoku Univ.). |
| HSC-39 | cell line derived from -666 |
| HSC-4 | A immortal human tongue-derived cell line cell that has the characteristics: Human tongue squamous cell carcinoma derived cell line. TKG0489 (Deposited from Tohoku Univ.). |
| HT | disease: diffuse mixed lymphoma; B lymphoblast |
| HT-1080 | |
| HT-115 | Human colon carcinoma cell line. |
| HT-1197 | |
| HT-1376 | |
| HT-144 | Homo sapiens (human), morphology: fibroblast, tissue: metastatic site: subcutaneous tissue malignant melanoma, established from a 29-year-old caucasian men. |
| HT-29 | |
| HT-3 | disease: carcinoma (cervix primary) |
| HT55 | |
| HTC-C3 | A immortal human thyroid gland-derived cell line cell that has the characteristics: Secretes IL-1,TGFα,KGM-CSF but not thyroglobulin |
| HUCCT1 | A immortal human cell line cell that has the characteristics: Human bile duct carcinoma. This cell line produces carbohydrate antigen 19/9 in serum-free medium. TKG0389(Deposited from Tohoku Univ.). |
| HUH-1 | cell line derived from liver |
| HUH-6-CLONE5 | cell line derived from liver |
| HUH-7 | HuH-7 is a well differentiated hepatocyte derived cellular carcinoma cell line that was originally taken from a liver tumor in a 57-year-old Japanese male in 1982. The line was established by Nakabayshi, H. and Sato, J. HuH-7 is an immortal cell line of epithelial-like tumorigenic cells. It usually grow in 2D monolayers. |
| HUO-3N1 | A immortal human cell line cell that has the characteristics: Human cell line derived from osteosarcoma. TKG0452(Deposited from Tohoku Univ.). |
| HUO9 | |
| HUP-T3 | |
| HUP-T4 | |
| HUTU-80 | |
| IA-LM | A immortal human cell line cell that has the characteristics: Japanese lung large cell carcinoma |
| IGR-1 | |
| IGR-37 | |
| IGROV-1 | |
| IHH-4 | cell line derived from -666 |
| IM-9 | Human B lymphoblastoid cell line (from patient with multiple myeloma); established from the bone marrow of a woman with multiple myeloma in 1967. Although derived from the blood of a patient with multiple myeloma, this line has been shown to be an EBV-transformed B lymphoblastoid cell line. |
| IM-95 | cell line derived from stomach |
| IMR-5 | |
| IPC-298 | |
| ISHIKAWA(HERAKLIO)02ER- | |
| IST-MEL1 | |
| IST-MES1 | disease: mesothelioma |
| IST-SL1 | disease: carcinoma, small cell |
| IST-SL2 | disease: carcinoma, small cell |
| J82 | |
| JAR | |
| JEG-3 | |
| JEKO-1 | |
| JHH-1 | cell line derived from liver |
| JHH-2 | cell line derived from liver |
| JHH-4 | cell line derived from liver |
| JHH-6 | cell line derived from liver |
| JHH-7 | cell line derived from liver |
| JHOS-2 | A immortal human ovary-derived fibroblast cell line cell that has the characteristics: Ovary serous adenocarcinoma. Said CA125, CA15-3 producing. |
| JHOS-3 | A immortal human ovary-derived fibroblast cell line cell that has the characteristics: Japanese ovarian serous adenocarcinoma. Said CA125 producing. Cell growth is slow. |
| JHOS-4 | A immortal human ovary-derived fibroblast cell line cell that has the characteristics: Human ovary serous cyst adenocarcinoma cell line. Cell growth is slow. |
| JHU-011 | Human head and neck squamous cell carcinoma (HNSCC) cell line. |
| JHU-022 | Human head and neck squamous cell carcinoma (HNSCC) cell line. |
| JHU-029 | Human head and neck squamous cell carcinoma (HNSCC) cell line. |
| JIMT-1 | |
| JIYOYEP-2003 | |
| JJN-3 | cell line derived from haematopoietic_and_lymphoid_tissue |
| JM1 | disease: leukemia; lymphoma |
| JSC-1 | disease: B cell lymphoma (metastatic site: peritoneal cavity) |
| JURKAT | Human T cell leukemia, established from the peripheral blood of a 14-year-old boy with acute lymphoblastic leukemia (ALL) at first relapse in 1976; often this cell line is called JM (JURKAT and JM are derived from the same patient and are sister clones), occasionally JM may be a subclone with somewhat divergent features. |
| JURL-MK1 | cell line derived from haematopoietic and lymphoid tissue |
| JVM-2 | disease: leukemia, chronic, B cell |
| JVM-3 | disease: leukemia, chronic, B cell |
| K-562 | Human chronic myeloid leukemia in blast crisis established from the pleural effusion of a 53-year-old woman with chronic myeloid leukemia (CML) in blast crisis in 1970. |
| K2 | cell line derived from -666 |
| K5 | |
| KALS-1 | |
| KARPAS-1106P | cell line derived from lymph node |
| KARPAS-231 | |
| KARPAS-299 | |
| KARPAS-422 | Human B cell lymphoma cell line; established from the pleural effusion of a 73-year-old woman with B cell non-Hodgkin lymphoma (intraabdominal, diffuse large cell lymphoma, refractory, terminal) in 1987. |
| KARPAS-45 | disease: leukemia, T cell |
| KARPAS-620 | cell line derived from haematopoietic_and_lymphoid_tissue |
| KASUMI-1 | Human acute myelocytic leukemia cell line; derived from the peripheral blood of a 7-year-old japanese boy with acute myelocytic leukemia in relapse after bone marrow transplantation. |
| KATOIII | |
| KCL-22 | A Philadelphia chromosome-positive cell line established from peripheral blood of a patient with chronic myelogenous leukemia in blast crisis. |
| KE-37 | Human T cell leukemia cell line; established from a 27-year-old man with acute lymphoblastic leukemia (ALL) in 1979. |
| KELLY | |
| KG-1 | A immortal human bone marrow-derived cell line cell that has the characteristics: Human acute myeloid leukemia. The variant subline (RCB1928 KG-1a) CD3-,CD13+,CD14-,CD15+,CD19-,CD33+ |
| KGN | A immortal human ovary-derived fibroblast cell line cell that has the characteristics: Granulosa cell tumor. Possible to produce progesterone after HCG addition. Cell growth is slow. |
| KINGS-1 | |
| KLE | |
| KM-H2 | Human Hodgkin lymphoma cell line, established from the pleural effusion of a 37-year-old man with Hodgkin lymphoma (mixed cellularity progressing to lymphocyte depletion; stage IV at relapse) in 1974. |
| KM12 | Human colon carcinoma cell line. |
| KMH-2 | Human Hodgkin lymphoma cell line, established from the pleural effusion of a 37-year-old man with Hodgkin lymphoma (mixed cellularity progressing to lymphocyte depletion; stage IV at relapse) in 1974. |
| KMOE-2 | disease: erythremia acute |
| KMRC-1 | cell line derived from kidney |
| KMRC-20 | cell line derived from kidney |
| KMS-11 | KMS-11 cell line was derived from four patients with multiple myeloma. These cells represent a later stage of B-cell differentiation, and shows characteristics of plasma cells by secreting surface kappa chain immunoglobulins. |
| KMS-12-BM | cell line derived from haematopoietic_and_lymphoid_tissue |
| KNS-42 | |
| KNS-62 | |
| KNS-81-FD | |
| KO52 | cell line derived from haematopoietic_and_lymphoid_tissue |
| KON | cell line derived from -666 |
| KOPN-8 | cell line derived from haematopoietic_and_lymphoid_tissue |
| KOSC-2 | |
| KP-1N | Human pancreatic cancer cell line, obtained from liver metastases of pancreatic tumors. |
| KP-2 | Human pancreatic cancer cell line of primary pancreatic origin. |
| KP-3 | Human pancreatic cancer cell line, obtained from liver metastases of pancreatic tumors. |
| KP-4 | A immortal human cell line cell that has the characteristics: Pancreatic ductal cell carcinoma. Mother cell line of KP4-1, -2, and -3. |
| KP-N-RT-BM-1 | |
| KP-N-YN | Human neuroblastoma cell line. |
| KP-N-YS | |
| KS-1 | |
| KU-19-19 | disease: carcinoma, transitional cell |
| KU812 | A immortal human blood cell line cell that has the characteristics: Chronic myelogeneous leukemia, Ph1 chromosome (+),basophi-like cells. |
| KURAMOCHI | |
| KY821 | |
| KYAE-1 | cell line derived from -666 |
| KYM-1 | cell line derived from soft_tissue |
| KYSE-140 | disease: carcinoma, squamous cell |
| KYSE-150 | Human esophageal squamous cell carcinoma cell line; established from the poorly differentiated esophageal squamous cell carcinoma resected from upper (cervical) esophagus of a 49-year-old Japanese woman after receiving radiotherapy. |
| KYSE-180 | disease: carcinoma, squamous cell |
| KYSE-220 | cell line derived from -666 |
| KYSE-270 | disease: carcinoma, squamous cell |
| KYSE-30 | |
| KYSE-410 | disease: carcinoma, squamous cell |
| KYSE-450 | disease: carcinoma, squamous cell |
| KYSE-50 | cell line derived from -666 |
| KYSE-510 | disease: carcinoma, squamous cell |
| KYSE-520 | disease: carcinoma, squamous cell |
| KYSE-70 | disease: carcinoma, squamous cell |
| L-1236 | cell line derived from haematopoietic_and_lymphoid_tissue |
| L-363 | Multiple myeloma cell line expressing syndecan-1. |
| L-428 | |
| L-540 | |
| LAMA-84 | Human chronic myeloid leukemia in blast crisis; established from the peripheral blood of a 29-year-old woman with chronic myeloid leukemia. |
| LAN-6 | |
| LB1047-RCC | |
| LB2241-RCC | |
| LB2518-MEL | |
| LB373-MEL-D | |
| LB647-SCLC | |
| LB771-HNC | |
| LB831-BLC | |
| LB996-RCC | |
| LC-1-SQ | A immortal human cell line cell that has the characteristics: Parent cell line of LC/sq-SFthe same patient as RCB0439 LC-F. Cell growth is slow. |
| LC-2-AD | A immortal human cell line cell that has the characteristics: Adenocarcinoma, moderately diffirentiated. Cell growth is slow. |
| LC4-1 | B-precursor acute lymphoblastic leukemia cell line. |
| LCLC-103H | disease: carcinoma, large cell |
| LCLC-97TM1 | disease: carcinoma, large cell |
| LIM1215 | Colonic cancer cell line. |
| LK-2 | A immortal human cell line cell that has the characteristics: Human lung squamous cell carcinoma cell line.TKG0494 (Deposited from Tohoku Univ.). |
| LN-18 | Human brain, cerebrum; right temporal lobe, glioblastoma; glioma; grade IV cell line; established from a 65 years old white male. |
| LN-229 | Human brain, right frontal parieto-occipital cortex, glioblastoma cell line; established from a 60 years old white female. |
| LN-405 | |
| LNCAP-CLONE-FGC | disease: carcinoma (prostate primary) |
| LNZTA3WT4 | disease: glioblastoma; p53 expression under tetracycline-induced promoter |
| LOU-NH91 | disease: carcinoma, squamous cell |
| LOUCY | disease: T lymphocyte; acute lympho- blastic leukemia; t(16;20) translocation |
| LOVO | A immortal human colon-derived cell line cell that has the characteristics: CEA-producing colon adenocarcinoma. Back up culture of ECA2739. Cell growth is slow. |
| LOXIMVI | Human melanoma cell line. |
| LP-1 | |
| LS-1034 | disease: colorectal carcinoma |
| LS-123 | |
| LS-180 | Human, Caucasian, colon, adenocarcinoma, colorectal, cell line. Morphology: epithelial; Species: human, Caucasian female 58 year old; Tissue: colon; Tumor: adenocarcinoma, colorectal. |
| LS-411N | disease: colorectal carcinoma |
| LS-513 | disease: colorectal carcinoma |
| LU-134-A | A immortal human cell line cell that has the characteristics: Small cell carcinoma, classic type. See Lu-134-B. |
| LU-135 | A immortal human cell line cell that has the characteristics: Small cell carcinoma, variant type |
| LU-139 | A immortal human cell line cell that has the characteristics: Small cell carcinoma, classic type |
| LU-165 | A immortal human cell line cell that has the characteristics: Producing high level of anti-diuretic hormone. |
| LU-65 | A immortal human cell line cell that has the characteristics: Human lung carcinoma cell line. TKG0442(Deposited from Tohoku Univ.). |
| LU-99A | |
| LXF-289 | |
| M059J | disease: malignant glioblastoma; glioma |
| M14 | The human melanoma cell line M14 has been established from surgically removed melanoma metastases. |
| MC-1010 | cell line derived from haematopoietic_and_lymphoid_tissue |
| MC-CAR | disease: hybridoma fusion partner |
| MC-IXC | |
| MC116 | |
| MCAS | cell line derived from ovary |
| MCC13 | cell line derived from -666 |
| MCC26 | cell line derived from -666 |
| MCF7 | A immortal human breast-derived cell line cell that has the characteristics: Human cell line derived from breast adenocarcinoma. TKG0479 (Deposited from Tohoku Univ.). |
| MDA-MB-157 | disease: carcinoma (mammary gland primary) |
| MDA-MB-175-VII | |
| MDA-MB-231 | |
| MDA-MB-330 | disease: carcinoma (mammary gland primary) |
| MDA-MB-361 | |
| MDA-MB-415 | disease: adenocarcinoma (mammary gland primary) |
| MDA-MB-436 | |
| MDA-MB-453 | |
| MDA-MB-468 | |
| MDST8 | cell line derived from large_intestine |
| ME-1 | disease: hybridoma |
| ME-180 | disease: epidermoid carcinoma (cervix primary) |
| MEG-01 | |
| MEL-HO | Human melanoma; established from the primary tumor of a woman with melanoma in 1976; cells express mRNA of the oncogene c-myc. |
| MEL-JUSO | Human melanoma, established from the primary tumor of a 58-year-old woman with melanoma in 1977. |
| MES-SA | disease: uterine sarcoma |
| MEWO | Human skin malignant melanoma cell line. |
| MFE-280 | |
| MFE-296 | |
| MFE-319 | |
| MFH-INO | A immortal human cell line cell that has the characteristics: Human fibrous histiocytoma. Showing fibroblastic- and histiocytic features. |
| MFM-223 | Human breast carcinoma; established from the pleural effusion of a post-menopausal breast cancer patient without any prior treatment (tumor: widespread ductal mammary carcinoma T4 N2 M1 with histological grade III); cells were described to express androgen, estrogen and progesterone receptors. |
| MG-63 | |
| MHH-CALL-2 | disease: leukemia, pre-B cell |
| MHH-CALL-4 | disease: leukemia, pre-B cell |
| MHH-ES-1 | |
| MHH-NB-11 | |
| MHH-PREB-1 | |
| MIA-PACA-2 | A immortal human cell line cell that has the characteristics: Human cell line derived from pancreatic cancer. TKG0227(Deposited from Tohoku Univ.) |
| MKN1 | A immortal human stomach-derived cell line cell that has the characteristics: Potentially differentiatable to both direction of adenomatous and squamous epithelial cells. |
| MKN28 | Well differentiated human gastric adenocarcinoma cell line. |
| MKN45 | Human gastric adenocarcinoma, established from the poorly differentiated adenocarcinoma of the stomach (medullary type) of a 62-year-old woman. |
| MKN7 | A immortal human stomach-derived cell line cell that has the characteristics: c-erbB-2 expressing gastric adenocarcinoma. Differentiated type. |
| ML-1 | Human acute myeloblastic leukaemia cell line from human peripheral blood. Morphology: Myoblast. |
| ML-2 | |
| MLMA | cell line derived from haematopoietic_and_lymphoid_tissue |
| MM1S | Human B lymphoblast multiple myeloma cell line. |
| MMAC-SF | |
| MN-60 | disease: leukemia, B cell |
| MO-T | |
| MOG-G-CCM | disease: astrocytoma, anaplastic |
| MOG-G-UVW | disease: astrocytoma, anaplastic |
| MOLM-13 | Human acute myeloid leukemia cell line; established from the peripheral blood of a 20-year-old man with acute myeloid leukemia AML FAB M5a at relapse in 1995 after initial myelodysplastic syndromes. |
| MOLM-16 | Human acute myeloid leukemia cell line; established in 1999 from the peripheral blood of a 77-year-old Japanese woman at relapse of acute myeloid leukemia (AML M0) after failed chemotherapy. |
| MOLP-8 | cell line derived from haematopoietic_and_lymphoid_tissue |
| MOLT-13 | Human T cell leukemia cell line; established from the bone marrow of a 2-year-old girl with T-ALL (T cell acute lymphoblastic leukemia, FAB L2) at relapse in 1983. |
| MOLT-16 | |
| MOLT-4 | |
| MONO-MAC-6 | Human acute monocytic leukemia cell line; established from the peripheral blood of a 64-year-old man with relapsed acute monocytic leukemia (AML FAB M5) in 1985 following myeloid metaplasia. Sister cell line of MONO-MAC-1. |
| MPP-89 | disease: mesothelioma |
| MRK-NU-1 | Human mammary gland carcinoma cell line, established from a 46 years old female. |
| MS-1 | |
| MS751 | disease: epidermoid carcinoma (cervix primary) |
| MSTO-211H | Human mesothelioma cell line; established from the pleural effusion of a 62-year-old Caucasian man with mesothelioma (malignant biphasic) who did not have any prior therapy. |
| MV-4-11 | Human acute myelocytic leukemia cell line. |
| MY-M12 | cell line derived from -666 |
| MZ1-PC | cell line derived from pancreas |
| MZ2-MEL | |
| MZ7-MEL | |
| NALM-6 | |
| NAMALWA | |
| NB(TU)1-10 | cell line derived from -666 |
| NB-4 | |
| NB1 | A immortal human adrenal gland-derived cell line cell that has the characteristics: Human cell line derived from neuroblastoma. Dibuty-cAMP (1 mM) induces differentiation. TKG0486(Deposited from Tohoku Univ.). |
| NB10 | |
| NB12 | |
| NB13 | |
| NB14 | Human neuroblastoma tumor cell line. |
| NB17 | |
| NB5 | Human neuroblastoma tumor cell line. |
| NB6 | |
| NB69 | A immortal somatic nervous system-derived cell line cell that has the characteristics: N-myc gene unamplified tumor. Cell growth is slow. |
| NB7 | Human neuroblastoma cell line. |
| NBSUSSR | A immortal human cell line cell that has the characteristics: Isolated from a patient with hiper dopaminemia andnorepinephrinemia. |
| NCC010 | cell line derived from -666 |
| NCC021 | cell line derived from -666 |
| NCCIT | Human pluripotent embryonal carcinoma, teratocarcinoma cell line; established in 1985 from a mediastinal mixed germ cell tumor of an adult Japanese male. This pluripotent stem cell line is capable of somatic and extraembryonic differentiation. |
| NCI-H1048 | disease: carcinoma; small cell lung cancer (lung primary) |
| NCI-H1092 | disease: carcinoma; classic small cell lung cancer (lung primary) |
| NCI-H1105 | disease: carcinoma; classic small cell lung cancer (lung primary) |
| NCI-H1155 | |
| NCI-H128 | Small cell lung cancer cell line. |
| NCI-H1299 | |
| NCI-H1304 | disease: carcinoma; classic small cell lung cancer (lung primary) |
| NCI-H1341 | disease: carcinoma; small cell lung cancer (lung primary) |
| NCI-H1355 | |
| NCI-H1395 | |
| NCI-H1417 | disease: carcinoma; classic small cell lung cancer |
| NCI-H1435 | Non-small cell lung cancer cell line. |
| NCI-H1436 | disease: carcinoma; classic small cell lung cancer (lung primary) |
| NCI-H1437 | |
| NCI-H146 | Small cell lung cancer cell line. |
| NCI-H1563 | disease: adenocarcinoma; non-small cell lung cancer |
| NCI-H1568 | disease: adenocarcinoma; non-small cell lung cancer (lung primary) |
| NCI-H1573 | disease: adenocarcinoma (lung primary) |
| NCI-H1581 | disease: large cell adenocarcinoma; non-small cell lung cancer |
| NCI-H1623 | disease: adenocarcinoma; non-small cell lung cancer (lung primary) |
| NCI-H1648 | disease: adenocarcinoma (lung primary) |
| NCI-H1650 | |
| NCI-H1651 | disease: adenocarcinoma; non-small cell lung cancer |
| NCI-H1666 | disease: adenocarcinoma; bronchoalveolar carcinoma (lung primary) |
| NCI-H1688 | disease: carcinoma; classic small cell lung cancer |
| NCI-H1693 | disease: adenocarcinoma; non-small cell lung cancer (lung primary) |
| NCI-H1694 | disease: carcinoma; classic small cell lung cancer (lung primary) |
| NCI-H1703 | |
| NCI-H1734 | disease: adenocarcinoma; non-small cell lung cancer |
| NCI-H1755 | disease: adenocarcinoma; non-small cell lung cancer (lung primary) |
| NCI-H1770 | disease: neuroendocrine carc- cinoma; non-small cell lung cancer (lung primary) |
| NCI-H1781 | disease: adenocarcinoma; bronchoalveolar carcinoma (lung primary) |
| NCI-H1792 | disease: adenocarcinoma (lung primary) |
| NCI-H1793 | disease: adenocarcinoma; non-small cell lung cancer |
| NCI-H1836 | disease: carcinoma; classic small cell lung cancer |
| NCI-H1838 | disease: adenocarcinoma; non-small cell lung cancer |
| NCI-H1869 | disease: squamous cell carcinoma (lung primary) |
| NCI-H187 | |
| NCI-H1876 | disease: carcinoma; classic small cell lung cancer (lung primary) |
| NCI-H1915 | Human non-small cell lung cancer cell line. |
| NCI-H1944 | disease: adenocarcinoma; non-small cell lung cancer (lung primary) |
| NCI-H196 | Small cell lung cancer cell line. |
| NCI-H1963 | disease: carcinoma; small cell lung cancer |
| NCI-H1975 | |
| NCI-H1993 | disease: adenocarcinoma; non-small cell lung cancer (lung primary) |
| NCI-H2009 | |
| NCI-H2023 | disease: adenocarcinoma; non-small cell lung cancer (lung primary) |
| NCI-H2029 | disease: carcinoma; small cell lung cancer (lung primary) |
| NCI-H2030 | disease: adenocarcinoma; non-small cell lung cancer (lung primary) |
| NCI-H2052 | disease: mesothelioma (pleura primary) |
| NCI-H2066 | disease: small cell lung cancer; adenocar- cinoma; squamous cell carcinoma |
| NCI-H2081 | disease: carcinoma; classic small cell lung cancer (lung primary) |
| NCI-H2085 | disease: adenocarcinoma; non-small cell lung cancer |
| NCI-H2087 | |
| NCI-H209 | Small cell lung cancer cell line. |
| NCI-H211 | Human small cell lung cancer cell line. |
| NCI-H2110 | disease: non-small cell lung cancer (lung primary) |
| NCI-H2122 | |
| NCI-H2126 | |
| NCI-H2135 | disease: non-small cell lung cancer |
| NCI-H2141 | disease: carcinoma; small cell lung cancer (lung primary) |
| NCI-H2170 | |
| NCI-H2171 | disease: carcinoma; small cell lung cancer (lung primary) |
| NCI-H2172 | disease: non-small cell lung cancer |
| NCI-H2196 | disease: carcinoma; small cell lung cancer (lung primary) |
| NCI-H2227 | disease: carcinoma; small cell lung cancer |
| NCI-H2228 | disease: adenocarcinoma; non-small cell lung cancer |
| NCI-H226 | |
| NCI-H2291 | disease: adenocarcinoma; non-small cell lung cancer (lung primary) |
| NCI-H23 | |
| NCI-H2342 | disease: adenocarcinoma; non-small cell lung cancer |
| NCI-H2347 | |
| NCI-H2405 | disease: adenocarcinoma; non-small cell lung cancer (lung primary) |
| NCI-H2444 | disease: non-small cell lung cancer |
| NCI-H2452 | disease: mesothelioma |
| NCI-H250 | disease: carcinoma; classic small cell lung cancer (lung primary) |
| NCI-H28 | disease: mesothelioma (pleura primary) |
| NCI-H292 | Mucoepidermoid human lung carcinoma cell line; established from a black female 32 years old; Morphology: epithelial. |
| NCI-H3122 | cell line derived from lung |
| NCI-H322M | Human non-small cell lung cancer cell line. |
| NCI-H345 | Small cell lung cancer cell line. |
| NCI-H358 | |
| NCI-H378 | disease: carcinoma; classic small cell lung cancer (lung primary) |
| NCI-H441 | |
| NCI-H446 | disease: carcinoma; small cell lung cancer (lung primary) |
| NCI-H460 | |
| NCI-H508 | disease: colorectal adenocarcinoma |
| NCI-H510A | disease: carcinoma; small cell lung cancer (unknown primary) |
| NCI-H520 | |
| NCI-H522 | |
| NCI-H524 | |
| NCI-H526 | Human small cell lung cancer cell line; established from a 55 years old caucasian male. |
| NCI-H596 | Human lung adenosquamous carcinoma cell line; derived in 1983 from a tumor mass in the chest wall of a patient with adenosquamous carcinoma of the lung. |
| NCI-H630 | disease: carcinoma (rectum primary) |
| NCI-H64 | |
| NCI-H647 | Human non-small cell lung adenosquamous carcinoma cell line, established from a 56 years old caucasian male. |
| NCI-H650 | disease: bronchioalveolar carci- noma; non-small cell lung cancer (lung primary) |
| NCI-H660 | Homo sapiens (human) lung; small cell lung cancer cell line, extrapulmonary origin; established from a 63 years adult caucasian male. Morphology: epithelial; cell type: neuroendocrine; Tumor stage E; derived from metastatic site: lymph node. |
| NCI-H661 | |
| NCI-H69 | Human Caucasian lung small cell carcinoma cell line. |
| NCI-H716 | |
| NCI-H720 | disease: atypical carcinoid |
| NCI-H727 | disease: carcinoid |
| NCI-H740 | disease: carcinoma; classic small cell lung cancer (lung primary) |
| NCI-H747 | disease: colorectal adenocarcinoma |
| NCI-H748 | disease: carcinoma; classic small cell lung cancer (lung primary) |
| NCI-H810 | disease: large cell; neuroendocrine; carcinoma; non-small cell lung cancer |
| NCI-H82 | |
| NCI-H820 | disease: papillary adenocarci- noma (lung primary) |
| NCI-H835 | disease: carcinoid |
| NCI-H838 | |
| NCI-H841 | disease: carcinoma; variant small cell lung cancer (lung primary) |
| NCI-H847 | disease: carcinoma; classic small cell lung cancer (lung primary) |
| NCI-H929 | Human multiple myeloma cell line; established from the pleural effusion of a 62-year-old white woman with myeloma (IgAkappa) at relapse. |
| NCI-N87 | |
| NCI-SNU-1 | |
| NCI-SNU-16 | |
| NCI-SNU-5 | |
| NEC8 | A immortal human testis-derived cell line cell that has the characteristics: Embryonal carcinoma, testis. |
| NH-12 | A immortal somatic nervous system-derived cell line cell that has the characteristics: Human cell line derived from neuroblastoma. TKG0448(Deposited from Tohoku Univ.). |
| NK-92MI | disease: IL-2 independent, cytotoxic to a wide range of malignant cells |
| NKM-1 | |
| NMC-G1 | |
| NO-10 | |
| NO-11 | |
| NOMO-1 | |
| NOS-1 | A immortal human bone element-derived cell line cell that has the characteristics: Osteoid producing in vitro and in nude mice. Cell growth is slow. |
| NTERA-2_CL_D1 | Testis; metastatic site: lung malignant pluripotent embryonal carcinoma cell line. The NTERA-2 cl.D1 cell line is a pluripotent human testicular embryonal carcinoma cell line derived by cloning the NTERA-2 cell line. |
| NU-DUL-1 | cell line derived from haematopoietic_and_lymphoid_tissue |
| NUGC-3 | Human gastric adenocarcinoma cell line established from a 72-year-old male. |
| NUGC-4 | A immortal human stomach-derived cell line cell that has the characteristics: Human cell line derived from signet ring cell carcinoma of stomach. TKG0449 (Deposited from Tohoku Univ.). |
| NY | |
| OACM5-1 | cell line derived from -666 |
| OACP4C | cell line derived from -666 |
| OAW-28 | |
| OAW-42 | disease: cystoadenocarcinoma |
| OC-314 | disease: cystoadenocarcinoma, low differentiated, papillary serous; G2/3 FIGO stage III c |
| OCI-AML2 | Human acute myeloid leukemia cell line; established from the peripheral blood of a 65-year-old man with acute myeloid leukemia. |
| OCI-AML3 | Human acute myeloid leukemia cell line; established from the peripheral blood of a 57-year-old man with acute myeloid leukemia. |
| OCI-AML5 | Human acute myeloid leukemia cell line; established from the peripheral blood of a 77-year-old man with acute myeloid leukemia. |
| OCI-LY-19 | cell line derived from haematopoietic_and_lymphoid_tissue |
| OCI-LY7 | |
| OCI-M1 | Human acute myeloid leukemia cell line; established from erythroleukemia blasts, AML M6, of a 62-year-old patient following a 7-year chlorambucil treatment for chronic lymphocytic leukemia. |
| OCUB-M | A immortal human mammary gland-derived cell line cell that has the characteristics: Same as OCUB-1, OCUB-F. Chromosome = pseudotetraploid. |
| OCUM-1 | cell line derived from stomach |
| OE19 | |
| OE21 | |
| OE33 | |
| OMC-1 | A immortal human uterine cervix-derived cell line cell that has the characteristics: Japanese cervix squamous cell carcinoma. Once said TA-4 positive. |
| ONS-76 | |
| OPM-2 | |
| OS-RC-2 | A immortal human kidney-derived cell line cell that has the characteristics: Renal tumor cell from a Japanese. Transplantable to nude mice. |
| OSC-19 | cell line derived from -666 |
| OSC-20 | cell line derived from -666 |
| OUMS-23 | cell line derived from large_intestine |
| OV-17R | cell line derived from ovary |
| OV-56 | cell line derived from ovary |
| OV-7 | cell line derived from ovary |
| OV-90 | |
| OVCA420 | Human epithelial ovarian cancer cell line. |
| OVCA433 | Human epithelial ovarian cancer cell line. |
| OVCAR-3 | |
| OVCAR-4 | |
| OVCAR-5 | |
| OVCAR-8 | |
| OVISE | Human ovarian carcinoma cell line from clear cell adenocarcinoma. |
| OVK-18 | A immortal human ovary-derived fibroblast cell line cell that has the characteristics: Human cell line derived from ovarial cancer, subclone of RCB2535. TKG0323 (Deposited from Tohoku Univ.). |
| OVKATE | Human ovarian carcinoma cell line from serous papillary adenocarcinoma. |
| OVMIU | cell line derived from -666 |
| OVTOKO | Human ovarian carcinoma cell line from clear cell adenocarcinoma. |
| P12-ICHIKAWA | Human T cell leukemia; established from the peripheral blood of a 7-year-old boy with acute lymphoblastic leukemia (ALL). |
| P30-OHK | A immortal human blood cell line cell that has the characteristics: Human cell line derived from T cell leukemia. TKG0463(Deposited from Tohoku Univ.). |
| P31-FUJ | |
| P32-ISH | cell line derived from -666 |
| PA-1 | Human ovary ascites teratocarcinoma cell line. The line was established from cells taken from ascitic fluid. |
| PA-TU-8902 | |
| PA-TU-8988T | |
| PANC-02-03 | |
| PANC-03-27 | |
| PANC-04-03 | |
| PANC-08-13 | |
| PANC-10-05 | disease: adenocarcinoma; same patient as PL45 |
| PC-14 | |
| PC-3 | |
| PC-3_[JPC-3] | cell line derived from -666 |
| PCI-15A | cell line derived from -666 |
| PCI-30 | cell line derived from -666 |
| PCI-38 | cell line derived from -666 |
| PCI-4B | cell line derived from -666 |
| PCI-6A | cell line derived from -666 |
| PE/CA-PJ15 | cell line derived from upper_aerodigestive_tract |
| PEO1 | |
| PF-382 | |
| PFSK-1 | disease: malignant primitive neuroectodermal tumor |
| PL-21 | cell line derived from haematopoietic_and_lymphoid_tissue |
| PL18 | cell line derived from -666 |
| PL4 | cell line derived from -666 |
| PSN1 | Human pancreatic adenocarcinoma cell line. |
| PWR-1E | Human prostatic epithelial cells, derived from a normal prostate with mild hyperplasia, were immortalized with an adenovirus 12-SV40 hybrid virus (Ad12-SV40). PWR-1E cell line was derived by single cell cloning of a non-producer cell. |
| QGP-1 | Human pancreatic neuroendocrine tumor cell line. |
| QIMR-WIL | disease: leukemia, myeloblastic |
| RAJI | |
| RAMOS-2G6-4C10 | disease: Burkitts lymphoma (American) |
| RC-K8 | cell line derived from blood |
| RCC-AB | cell line derived from kidney |
| RCC-ER | cell line derived from kidney |
| RCC-FG2 | cell line derived from kidney |
| RCC-JF | cell line derived from kidney |
| RCC-JW | cell line derived from kidney |
| RCC-MF | cell line derived from kidney |
| RCC10RGB | A immortal human kidney-derived cell line cell that has the characteristics: Kidney carcinoma from a Japanese patient. Cell growth is slow. |
| RCH-ACV | |
| RCM-1 | |
| RD | |
| REH | Human B cell precursor leukemia established from the peripheral blood of a 15-year-old North African girl with acute lymphoblastic leukaemia, ALL at first relapse, in 1973. |
| RERF-GC-1B | cell line derived from stomach |
| RERF-LC-FM | cell line derived from lung |
| RERF-LC-KJ | A immortal human cell line cell that has the characteristics: Japanese lung adenocarcinoma, highly metastatic in SCID mice. Also refer to RCB0444 RCRF-LC-AI. Cell growth is slow. |
| RERF-LC-MS | |
| RERF-LC-SQ1 | cell line derived from lung |
| RF-48 | cell line derived from stomach |
| RH-1 | Human rhabdomyosarcoma cell line. |
| RH-18 | Human rhabdomyosarcoma cell line. |
| RH-41 | cell line derived from soft_tissue |
| RKN | cell line derived from soft_tissue |
| RKO | |
| RL | |
| RL95-2 | |
| RMG-I | Human tumor cell line from ovarian mesonephroid adenocarcinoma. |
| RO82-W-1 | |
| ROS-50 | cell line derived from -666 |
| RPMI-2650 | Human nasal septum squamous cell carinoma cell line; established from the pleural effusion of a 52-year-old man with anaplastic squamous cell carcinoma of the nasal septum in 1962. |
| RPMI-6666 | disease: Hodgkins disease |
| RPMI-7951 | Human skin malignant melanoma cells that can be ordered from ATCC. This is a hyperdiploid human cell line with the modal chromosome number of 49, occurring in 24% of cells. Polyploid cells occurred at 22%, which is high. Cells are adherent, and were first harvested in 1971 from a metastatic site in a lymph node. |
| RPMI-8226 | |
| RPMI-8402 | Human T cell acute lymphoblastic leukemia cell line; established from the peripheral blood of a 16-year-old woman with acute lymphoblastic leukemia (ALL) in 1972. |
| RPMI-8866 | Human B lymphoid cell line, established from the peripheral blood of a 51-year-old American woman with chronic myelogenous leukemia in May 1966. |
| RS4-11 | Human B cell precursor leukemia cell line; established from the bone marrow of a 32-year-old woman with acute lymphoblastic leukemia (ALL L2) in first relapse. |
| RT-112 | Human urinary bladder transitional cell carcinoma established from the transitional cell carcinoma histological grade G2 excised from a female patient with untreated primary urinary bladder carcinoma in 1973. |
| RT4 | Human urinary bladder transitional cell carcinoma; established from a recurrent well-differentiated transitional papillary tumor of the urinary bladder (clinical stage T2, histological grade G1, treated with gold grains 2 years earlier and diathermy after recurrence 10 months later) of a 63-year-old man in 1968. |
| RVH-421 | |
| RXF393 | Renal cancer cell line. |
| S-117 | |
| SAOS-2 | Human osteogenic sarcoma, established from the primary osteogenic sarcoma of an 11-year-old Caucasian woman in 1973. |
| SARC9371 | cell line derived from -666 |
| SAS | A immortal human tongue-derived cell line cell that has the characteristics: Human cell line derived from tongue cancer. Squamous cell carcinoma. TKG0470(Deposited from Tohoku Univ.). |
| SAT | cell line derived from -666 |
| SBC-1 | Human small cell lung cancer cell line. |
| SBC-3 | cell line derived from lung |
| SBC-5 | |
| SC-1 | A immortal mouse embryo-derived cell line cell that has the characteristics: Embryonal cell line derived from wild mouse. Sensitive to leukemia viruses. |
| SCABER | |
| SCC-15 | Human tongue squamous cell carcinoma cell line. |
| SCC-25 | Human squamous cell carcinoma cell line; established from the biopsy of a squamous cell carcinoma of the tongue of a 70-year-old man. |
| SCC-3 | |
| SCC-4 | Human squamous cell carcinoma cell line; established from the squamous cell carcinoma of the tongue from a 55-year-old man after radio- and chemotherapy in 1980. |
| SCC-9 | disease: squamous cell carcinoma |
| SCC90 | cell line derived from -666 |
| SCH | |
| SET2 | Acute myeloid leukemia cell line. Human essential thrombocythemia cell line; established from the peripheral blood of a 71-year-old woman with essential thrombocythemia at megakaryoblastic leukemic transformation. |
| SF126 | |
| SF268 | |
| SF295 | |
| SF539 | |
| SH-4 | |
| SHP-77 | |
| SIG-M5 | disease: leukemia, acute monocytic |
| SIHA | |
| SIMA | |
| SISO | |
| SJRH30 | disease: rhabdomyosarcoma (muscle primary) |
| SJSA-1 | |
| SK-CO-1 | disease: colorectal adenocarcinoma (colon primary) |
| SK-ES-1 | disease: sarcoma (anaplastic osteosarcoma or Ewings sarcoma) |
| SK-GT-2 | cell line derived from -666 |
| SK-GT-4 | |
| SK-HEP-1 | Human liver adenocarcinoma cell line; established from the ascites of a 52-year-old Caucasian man in 1971. |
| SK-LMS-1 | |
| SK-LU-1 | Non-small cell lung cancer cell line. |
| SK-MEL-1 | |
| SK-MEL-2 | |
| SK-MEL-24 | disease: malignant melanoma |
| SK-MEL-28 | |
| SK-MEL-3 | |
| SK-MEL-30 | Human melanoma derived from tumor tissue (subcutis metastasis) of a 67-year-old Caucasian man with malignant melanoma in 1975. |
| SK-MEL-31 | disease: malignant melanoma |
| SK-MEL-5 | Human caucasian skin melanoma cell line; established from a 24 year old Caucasian female. Derived from: axillary node. |
| SK-MES-1 | |
| SK-MG-1 | |
| SK-MM-2 | |
| SK-N-AS | |
| SK-N-DZ | Neuroblastoma cell line derived in 1978 from a bone marrow metastasis from a 2 years old caucasian female child with poorly differentiated embryonal neuroblastoma. |
| SK-N-FI | Neuroblastoma cell line; derived in 1979 from a bone marrow metastasis from a 11 year old Caucasian male with poorly differentiated embryonal neuroblastoma. |
| SK-N-SH | |
| SK-NEP-1 | disease: Wilmstumor (kidney primary) |
| SK-OV-3 | |
| SK-PN-DW | disease: retroperitoneal; malignant; primitive neuroectodermal tumor |
| SK-UT-1 | |
| SKG-IIIA | A immortal human uterine cervix-derived cell line cell that has the characteristics: Cervical carcinoma cell line derived from human. TA-4, CA-4, TPA, placental ALP are positive. Regan isoenzyme producing. p53 normal, p51 mutation (+), HLA-A 2402/.TKG0462(Deposited from Tohoku Univ.). |
| SKM-1 | |
| SKN | A immortal human endometrium-derived cell line cell that has the characteristics: Estradiol-17 beta responsive leiomyosarcoma |
| SKN-3 | cell line derived from -666 |
| SLVL | A immortal human spleen-derived cell line cell that has the characteristics: Human cell line derived from splenic B cell lymphoma. |
| SN12C | Human renal cell carcinoma cell line. |
| SNB75 | Human glioblastoma cell line. |
| SNG-M | |
| SNU-1040 | cell line derived from large_intestine |
| SNU-175 | cell line derived from large_intestine |
| SNU-182 | |
| SNU-283 | cell line derived from large_intestine |
| SNU-387 | |
| SNU-398 | |
| SNU-407 | cell line derived from large_intestine |
| SNU-423 | |
| SNU-449 | |
| SNU-475 | |
| SNU-61 | cell line derived from large intestine |
| SNU-81 | cell line derived from large_intestine |
| SNU-C1 | disease: adenocarcinoma colon primary) |
| SNU-C2B | disease: colorectal carcinoma |
| SNU-C5 | cell line derived from large_intestine |
| SR | |
| ST486 | disease: Burkitts lymphoma |
| STS-0421 | cell line derived from -666 |
| SU-DHL-1 | |
| SU-DHL-10 | |
| SU-DHL-16 | |
| SU-DHL-4 | cell line derived from haematopoietic_and_lymphoid_tissue |
| SU-DHL-5 | |
| SU-DHL-6 | |
| SU-DHL-8 | cell line derived from haematopoietic_and_lymphoid_tissue |
| SU8686 | Homo sapiens (human) pancreatic adenocarcinoma cell line. The line was developed from a wedge biosy of a liver metastasis of a pancreatic ductal carcinoma. |
| SUIT-2 | Human pancreatic cancer cell line. |
| SUP-B15 | disease: acute lymphoblastic leukemia |
| SUP-B8 | cell line derived from haematopoietic_and_lymphoid_tissue |
| SUP-HD1 | cell line derived from haematopoietic_and_lymphoid_tissue |
| SUP-M2 | Human anaplastic large cell lymphoma (ALCL) cell line; derived from the cerebrospinal fluid of a 5-year-old girl with refractory malignant histiocytosis. |
| SUP-T1 | Human T cell lymphoma cell line; established from the pleural effusion of an 8-year-old boy with T-lymphoblastic lymphoma in relapse. |
| SW1088 | |
| SW1116 | |
| SW1271 | disease: carcinoma; small cell lung cancer |
| SW13 | |
| SW1417 | |
| SW1463 | |
| SW156 | disease: hypernephroma |
| SW1573 | |
| SW1710 | disease: carcinoma, transitional cell |
| SW1783 | disease: astrocytoma |
| SW1990 | |
| SW403 | |
| SW48 | |
| SW620 | |
| SW626 | Human, ovary, adenocarcinoma cell line. |
| SW684 | disease: fibrosarcoma |
| SW756 | disease: squamous cell carcinoma |
| SW780 | disease: transitional cell carcinoma |
| SW837 | |
| SW872 | |
| SW900 | |
| SW948 | |
| SW954 | disease: squamous cell carcinoma |
| SW962 | disease: carcinoma (vulva primary) |
| SW982 | disease: synovial sarcoma |
| T-24 | |
| T-T | |
| T47D | |
| T84 | |
| T98G | A immortal human brain-derived cell line cell that has the characteristics: Human cell line derived from glioblastoma multiforme (Caucasian). Hyperpentaploid chromosome count. TKG0471(Deposited from Tohoku Univ.). |
| TALL-1 | A immortal human bone marrow-derived cell line cell that has the characteristics: Human T-cell line derived from acute lynphblastic leukemia. TKG0251 (Deposited from Tohoku Univ.). |
| TASK1 | cell line derived from -666 |
| TC-71 | |
| TC-YIK | A immortal human uterine cervix-derived cell line cell that has the characteristics: Integrating HPV16, neurosecretory granules(+) |
| TCCSUP | disease: transitional cell carcinoma |
| TE-1 | A immortal human esophagus-derived cell line cell that has the characteristics: Human cell line derived from esophageal cancer. Squamous cell carcinoma. TKG0462(Deposited from Tohoku Univ.). |
| TE-10 | A immortal human esophagus-derived cell line cell that has the characteristics: Human cell line derived from esophageal cancer. Highly differentiated squamous cell carcinoma. TKG0261(Deposited from Tohoku Univ.). |
| TE-11 | A immortal human esophagus-derived cell line cell that has the characteristics: Human cell line derived from esophageal cancer. Moderately differentiated squamous cell carcinoma. TKG0262(Deposited from Tohoku Univ.). |
| TE-12 | |
| TE-15 | Human esophageal squamous cell carcinoma cell line. |
| TE-4 | A immortal human esophagus-derived cell line cell that has the characteristics: Human cell line derived from esophageal cancer. Highly differentiated squamous cell carcinoma.TKG0255(Deposited from Tohoku Univ.). |
| TE-441-T | disease: rhabdomyosarcoma |
| TE-5 | A immortal human esophagus-derived cell line cell that has the characteristics: Human cell line derived from poorly differntiated esophageal squamous cell carcinoma. Not transplantable to nude mouse. TKG0256 (Deposited from Tohoku Univ.). |
| TE-6 | A immortal human esophagus-derived cell line cell that has the characteristics: Highly differentiated squamous carcinoma (esophagus), not transplantable to nude mouse. A culture submitted to the Cell Resource Center for Biomedical Research was found to be contaminated with mycoplasma. Progeny were cured by Treatments with BM Cyclin and MC210. TKG0257 (Deposited from Tohoku Univ.). |
| TE-8 | A immortal human esophagus-derived cell line cell that has the characteristics: Human cell line derived from esophageal cancer. Moderately differentiated squamous cell carcinoma. TKG0259(Deposited from Tohoku Univ.). |
| TE-9 | A immortal human esophagus-derived cell line cell that has the characteristics: Human esophageal squamous cell carcinoma (poorly differentiated) cell line. Not transplantable to nude mouse. TKG0260 (Deposited from Tohoku Univ.). |
| TGBC11TKB | A immortal human stomach-derived cell line cell that has the characteristics: Japanese gastric cancer, lymph node metastated. |
| TGBC1TKB | A immortal human cell line cell that has the characteristics: Japanese gallbadder carcinoma metastated to lymph node from the same patient of TGBC2TKB. Cell growth is slow. |
| TGBC24TKB | A immortal human cell line cell that has the characteristics: Japanese gallbladder carcinoma established from metastated ascite. Cell growth is slow. |
| TGW | |
| THP-1 | |
| TK | cell line derived from blood |
| TK10 | TK-10 was derived from a specimen of primary RCC obtained following a left radical nephrectomy in a 43-year-old male on August 21, 1980. |
| TMK-1 | |
| TOV-112D | TOV-112D is a human epithelial cell line initiated in October of 1992 from a patient with early onset ovarian cancer. The patient was of French-Canadian descent with an unknown family history of ovarian cancer. |
| TOV-21G | This cell line was initiated in October of 1991 from a patient of French-Canadian descent with no family history of ovarian cancer. |
| TT | |
| TT2609-C02 | cell line derived from thyroid |
| TUR | disease: histiocytic lymphoma; neomycin resistant |
| TYK-NU | |
| U-118-MG | Human neuronal glioblastoma (grade III) cell line. |
| U-2-OS | |
| U-266 | Human multiple myeloma cell line; established from the peripheral blood of a 53-year-old man with IgE-secreting myeloma (refractory, terminal) in 1968. |
| U-698-M | disease: lymphoma, B cell |
| U-87-MG | Human, Caucasian, brain, glioblastoma-astrocytoma cell line Morphology: epithelial-like; Species: human, Caucasian female 44 years old; Tissue: brain; Tumor: glioblastoma-astrocytoma. |
| U-CH2 | cell line derived from bone |
| U031 | |
| U251 | Human glioma cell line. Morphology: glial; Species: human; Tumor: glioma. |
| UACC-257 | |
| UACC-62 | |
| UACC-812 | disease: ductal carcinoma |
| UACC-893 | |
| UDSCC2 | cell line derived from -666 |
| UM-UC-3 | |
| UMC-11 | disease: carcinoid |
| UWB1_289 | cell line derived from ovary |
| VA-ES-BJ | disease: carcinoma, epithelioid (bone primary) |
| VAL | |
| VCAP | Human prostate cancer cell line. |
| VM-CUB-1 | disease: carcinoma, transitional cell |
| VMRC-LCD | cell line derived from lung |
| VMRC-MELG | cell line derived from skin |
| VMRC-RCW | A immortal human kidney-derived cell line cell that has the characteristics: Human renal cell carcinoma cell line. TKG0447(Deposited from Tohoku Univ.). |
| VMRC-RCZ | Human renal carcinoma cell line. |
| WIL2-NS | Spleen; B lymphocyte; hereditary spherocytosis cell line, established from a caucasion 5 year old male. The line was derived from the WIL-2 B cell line. |
| WM-115 | |
| WM1552C | disease: primary superficial spreading melanoma in radial growth phase/vertical growth phase |
| WM278 | This cell line was established from skin taken from a patient with primary nodular melanoma in vertical growth phase. |
| WM35 | Human melanoma cell line, derived from the primary radial growth phase tumor site. |
| WM793B | The WM793B line was established from skin taken from the primary melanoma of a vertical growth phase lesion taken from the sternum of a patient. |
| WSU-DLCL2 | cell line derived from haematopoietic_and_lymphoid_tissue |
| WSU-NHL | |
| YAPC | |
| YH-13 | |
| YKG-1 | A immortal human brain-derived cell line cell that has the characteristics: Human cell line derived from glioblastoma. TKG0453(Deposited from Tohoku Univ.). |
| YMB-1-E | Human breast cancer cell line; established from a 55 year-old female. |
| YT | Human T/NK cell leukemia cell line, established from the pericardial fluid of a 15-year-old man with acute lymphoblastic leukemia (ALL) at relapse (with accompanying thymoma) in 1983. |
| ZR-75-30 |
